Howard Berman - Net Worth and Insider Trading

Howard Berman Net Worth

The estimated net worth of Howard Berman is at least $7 Million dollars as of 2024-05-30. Howard Berman is the CEO, 10% Owner of Coya Therapeutics Inc and owns about 959,338 shares of Coya Therapeutics Inc (COYA) stock worth over $7 Million. Details can be seen in Howard Berman's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Howard Berman has not made any transactions after 2023-01-03 and currently still holds the listed stock(s).

Transaction Summary of Howard Berman

To

Howard Berman Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Howard Berman owns 1 companies in total, including Coya Therapeutics Inc (COYA) .

Click here to see the complete history of Howard Berman’s form 4 insider trades.

Insider Ownership Summary of Howard Berman

Ticker Comapny Transaction Date Type of Owner
COYA Coya Therapeutics Inc 2023-01-03 director & 10 percent owner & Chief Executive Officer

Howard Berman Latest Holdings Summary

Howard Berman currently owns a total of 1 stock. Howard Berman owns 959,338 shares of Coya Therapeutics Inc (COYA) as of January 3, 2023, with a value of $7 Million.

Latest Holdings of Howard Berman

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
COYA Coya Therapeutics Inc 2023-01-03 959,338 7.37 7,070,321

Holding Weightings of Howard Berman


Howard Berman Form 4 Trading Tracker

According to the SEC Form 4 filings, Howard Berman has made a total of 1 transactions in Coya Therapeutics Inc (COYA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Coya Therapeutics Inc is the acquisition of 10,000 shares on January 3, 2023, which cost Howard Berman around $46,500.

Insider Trading History of Howard Berman

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Howard Berman Trading Performance

GuruFocus tracks the stock performance after each of Howard Berman's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Howard Berman is -12.9%. GuruFocus also compares Howard Berman's trading performance to market benchmark return within the same time period. The performance of stocks bought by Howard Berman within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Howard Berman's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Howard Berman

Average Return

Average return per transaction

Outperforming Transactions

1 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -14.19
Relative Return to S&P 500(%) -22.36

Howard Berman Ownership Network

Ownership Network List of Howard Berman

No Data

Ownership Network Relation of Howard Berman


Howard Berman Owned Company Details

What does Coya Therapeutics Inc do?

Who are the key executives at Coya Therapeutics Inc?

Howard Berman is the director & 10 percent owner & Chief Executive Officer of Coya Therapeutics Inc. Other key executives at Coya Therapeutics Inc include Chief Medical Officer Fred Grossman , Chief Medical Officer Adrian Hepner , and Chief Financial Officer David S Snyder .

Coya Therapeutics Inc (COYA) Insider Trades Summary

Over the past 18 months, Howard Berman made 1 insider transaction in Coya Therapeutics Inc (COYA) with a net purchase of 10,000. Other recent insider transactions involving Coya Therapeutics Inc (COYA) include a net purchase of 11,000 shares made by Ann Lee , a net purchase of 10,000 shares made by Anabella Villalobos , and a net purchase of 10,000 shares made by Adrian Hepner .

In summary, during the past 3 months, insiders sold 0 shares of Coya Therapeutics Inc (COYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Coya Therapeutics Inc (COYA) were sold and 60,000 shares were bought by its insiders, resulting in a net purchase of 60,000 shares.

Coya Therapeutics Inc (COYA)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Coya Therapeutics Inc Insider Transactions

No Available Data

Howard Berman Mailing Address

Above is the net worth, insider trading, and ownership report for Howard Berman. You might contact Howard Berman via mailing address: C/o Coya Therapeutics, Inc., 5850 San Felipe St., Suite 500, Houston Tx 77057.

Discussions on Howard Berman

No discussions yet.